
Remaining special in the specialty pharmacy space requires innovation.

Remaining special in the specialty pharmacy space requires innovation.

Specialty pharmacies must be prepared to innovate as biosimilars hit the US market.

Specialty pharmacy providers are uniquely positioned to capture information on a wide array of outcomes.

Specialty pharmacies must engage each individual patient to ensure optimal treatment outcomes.

Prescribers and patients can no longer blindly rely on simple and straightforward drug delivery in specialty pharmacy.

Optimal channel selection should be made with the patient’s best interest at the center of the decision.

Published: July 22nd 2016 | Updated:

Published: August 1st 2016 | Updated:

Published: August 17th 2016 | Updated:

Published: September 26th 2016 | Updated:

Published: November 14th 2016 | Updated:

Published: January 18th 2017 | Updated: